TRANS GENIC INC. News Releases 2006

2006


Dec.20	Notice of Conclusion of Agency Agreement with TriStar Technology Group, LLC. (USA)
Dec.15	Regarding Patent for GANP® Genes Granted in the U.S.
Nov.20	Notice of Conclusion of License Agreement for High-affinity Antibody Technology using GANP Mouse
Nov.01	Improvement of R&D Functions of Kobe Research Center
Oct.30	TRANS GENIC’s subject was selected for “Collaborative Development of Innovative Seeds, Potentiality Verification Stage” of JST
Oct.16	Notice of Introduction of New Antibody-Producing Technology (DNA Immunization) and Launch of the Related Business
Oct.02	Launch of Contract Research based on Agreement with JST
Sep.21	Notice of Launching "TG Resource Bank" Business
Sep.20	Agreement Concluded on Business Tie-up between genOway and TRANS GENIC
Jul.13	Notice of Conclusion of License Agreement for “Anti-HIV antibody”
Jun.29	Acquisition of Patent on Assay System for Cancer Diagnosis Using Urine Samples
May 15	Primmune K. K. becomes a subsidiary of TRANS GENIC INC.
May 15	Notice of Partial Amendment to Articles of Incorporation
May 15	Notice of Reverse Split of Shares
May 15	Notice of Reduction of Capital Reserve.
May 10	Notice of Earnings Forecast for Fiscal Year Ending March 31, 2006
Apr.24	High-affinity Antibody Technology using GANP Mouse: The Development of In Vitro Diagnostic Products
Mar.20	Notice on Completion of Early Redemption and Cancellation of Unsecured Convertible Bonds with Stock Acquisition Rights and Stock Acquisition Rights issued by TRANS GENIC INC.
Feb.17	TRANS GENIC and Livedoor Group Agree on Dissolution of Comprehensive Business Tie-up Regarding Bio-related Business
Feb.17	Early Redemption and Cancellation of Convertible Bonds with Stock Acquisition Rights and Stock Acquisition Rights, and Dissolution of Management and Advisory Agreement with Livedoor Securities Co., Ltd.

>>2010
>>2009
>>2008
>>2007
>>2006
>>2005
>>2004
>>2003
>>2002